At a glance
ClinicalIndex Comparison RecordN/ACompleted· 24 enrolled
Drug / intervention
Aurora Endometrial Ablation Systemdevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
A Single Arm Clinical Study of the Safety and Efficacy of the AURORA™ Endometrial Ablation System
In Brief
A clinical study evaluating Aurora Endometrial Ablation System for Menorrhagia Due to Benign Causes. Completed, enrolled 24 participants across 1 site.
Detailed Summary
This is a clinical study without a formal hypothesis. The primary objective of the study is to evaluate the use of the Aurora Endometrial Ablation System in achieving a return to normal menstrual blood loss at 12 months post-treatment, in premenopausal women with menorrhagia due to benign causes for whom childbearing is complete or no longer wish to retain fertility.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsMenorrhagia Due to Benign Causes
CountriesMexico
Collaborators--
Timeline
N/ACompletedFinished
201220132014201520162017201820192020202120222023202420252026
Enrollment StartAug 2011
Primary CompletionOct 2012
First PostedDec 2013
Study CompletionMay 2015
TodayJul 2026
First PostedDec 30, 2013
Enrollment StartAug 1, 2011
Primary CompletionOct 1, 2012
Study CompletionMay 1, 2015
TodayJul 2, 2026
Enrollment to primary: 1.2 yearsPosted 12.5 years ago
Interventions
Aurora Endometrial Ablation Systemdevice
Ablation of the endometrial lining of the uterus using the Aurora System